Biochemical Characterization of the GBA2 c.1780G>C Missense Mutation in Lymphoblastoid Cells from Patients with Spastic Ataxia

The GBA2 gene encodes the non-lysosomal glucosylceramidase (NLGase), an enzyme that catalyzes the conversion of glucosylceramide (GlcCer) to ceramide and glucose. Mutations in GBA2 have been associated with the development of neurological disorders such as autosomal recessive cerebellar ataxia, here...

Full description

Bibliographic Details
Main Authors: Anna Malekkou, Maura Samarani, Anthi Drousiotou, Christina Votsi, Sandro Sonnino, Marios Pantzaris, Elena Chiricozzi, Eleni Zamba-Papanicolaou, Massimo Aureli, Nicoletta Loberto, Kyproula Christodoulou
Format: Article
Language:English
Published: MDPI AG 2018-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/19/10/3099
id doaj-4c10326ea8924aeaa8c2371324a73547
record_format Article
spelling doaj-4c10326ea8924aeaa8c2371324a735472020-11-24T21:24:58ZengMDPI AGInternational Journal of Molecular Sciences1422-00672018-10-011910309910.3390/ijms19103099ijms19103099Biochemical Characterization of the GBA2 c.1780G>C Missense Mutation in Lymphoblastoid Cells from Patients with Spastic AtaxiaAnna Malekkou0Maura Samarani1Anthi Drousiotou2Christina Votsi3Sandro Sonnino4Marios Pantzaris5Elena Chiricozzi6Eleni Zamba-Papanicolaou7Massimo Aureli8Nicoletta Loberto9Kyproula Christodoulou10Biochemical Genetics Department, The Cyprus Institute of Neurology and Genetics, Nicosia 1683, CyprusDepartment of Medical Biotechnology and Translational Medicine, University of Milano, 20122 Milano, ItalyBiochemical Genetics Department, The Cyprus Institute of Neurology and Genetics, Nicosia 1683, CyprusCyprus School of Molecular Medicine, Nicosia 1683, CyprusDepartment of Medical Biotechnology and Translational Medicine, University of Milano, 20122 Milano, ItalyCyprus School of Molecular Medicine, Nicosia 1683, CyprusDepartment of Medical Biotechnology and Translational Medicine, University of Milano, 20122 Milano, ItalyCyprus School of Molecular Medicine, Nicosia 1683, CyprusDepartment of Medical Biotechnology and Translational Medicine, University of Milano, 20122 Milano, ItalyDepartment of Medical Biotechnology and Translational Medicine, University of Milano, 20122 Milano, ItalyCyprus School of Molecular Medicine, Nicosia 1683, CyprusThe GBA2 gene encodes the non-lysosomal glucosylceramidase (NLGase), an enzyme that catalyzes the conversion of glucosylceramide (GlcCer) to ceramide and glucose. Mutations in GBA2 have been associated with the development of neurological disorders such as autosomal recessive cerebellar ataxia, hereditary spastic paraplegia, and Marinesco-Sjogren-Like Syndrome. Our group has previously identified the GBA2 c.1780G>C [p.Asp594His] missense mutation, in a Cypriot consanguineous family with spastic ataxia. In this study, we carried out a biochemical characterization of lymphoblastoid cell lines (LCLs) derived from three patients of this family. We found that the mutation strongly reduce NLGase activity both intracellularly and at the plasma membrane level. Additionally, we observed a two-fold increase of GlcCer content in LCLs derived from patients compared to controls, with the C16 lipid being the most abundant GlcCer species. Moreover, we showed that there is an apparent compensatory effect between NLGase and the lysosomal glucosylceramidase (GCase), since we found that the activity of GCase was three-fold higher in LCLs derived from patients compared to controls. We conclude that the c.1780G>C mutation results in NLGase loss of function with abolishment of the enzymatic activity and accumulation of GlcCer accompanied by a compensatory increase in GCase.http://www.mdpi.com/1422-0067/19/10/3099GBA2non-lysosomal β-glucosylceramidaseβ-glucocerebrosidasespastic ataxiaglucosylceramideplasma membranelymphoblastoid cell lines
collection DOAJ
language English
format Article
sources DOAJ
author Anna Malekkou
Maura Samarani
Anthi Drousiotou
Christina Votsi
Sandro Sonnino
Marios Pantzaris
Elena Chiricozzi
Eleni Zamba-Papanicolaou
Massimo Aureli
Nicoletta Loberto
Kyproula Christodoulou
spellingShingle Anna Malekkou
Maura Samarani
Anthi Drousiotou
Christina Votsi
Sandro Sonnino
Marios Pantzaris
Elena Chiricozzi
Eleni Zamba-Papanicolaou
Massimo Aureli
Nicoletta Loberto
Kyproula Christodoulou
Biochemical Characterization of the GBA2 c.1780G>C Missense Mutation in Lymphoblastoid Cells from Patients with Spastic Ataxia
International Journal of Molecular Sciences
GBA2
non-lysosomal β-glucosylceramidase
β-glucocerebrosidase
spastic ataxia
glucosylceramide
plasma membrane
lymphoblastoid cell lines
author_facet Anna Malekkou
Maura Samarani
Anthi Drousiotou
Christina Votsi
Sandro Sonnino
Marios Pantzaris
Elena Chiricozzi
Eleni Zamba-Papanicolaou
Massimo Aureli
Nicoletta Loberto
Kyproula Christodoulou
author_sort Anna Malekkou
title Biochemical Characterization of the GBA2 c.1780G>C Missense Mutation in Lymphoblastoid Cells from Patients with Spastic Ataxia
title_short Biochemical Characterization of the GBA2 c.1780G>C Missense Mutation in Lymphoblastoid Cells from Patients with Spastic Ataxia
title_full Biochemical Characterization of the GBA2 c.1780G>C Missense Mutation in Lymphoblastoid Cells from Patients with Spastic Ataxia
title_fullStr Biochemical Characterization of the GBA2 c.1780G>C Missense Mutation in Lymphoblastoid Cells from Patients with Spastic Ataxia
title_full_unstemmed Biochemical Characterization of the GBA2 c.1780G>C Missense Mutation in Lymphoblastoid Cells from Patients with Spastic Ataxia
title_sort biochemical characterization of the gba2 c.1780g>c missense mutation in lymphoblastoid cells from patients with spastic ataxia
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2018-10-01
description The GBA2 gene encodes the non-lysosomal glucosylceramidase (NLGase), an enzyme that catalyzes the conversion of glucosylceramide (GlcCer) to ceramide and glucose. Mutations in GBA2 have been associated with the development of neurological disorders such as autosomal recessive cerebellar ataxia, hereditary spastic paraplegia, and Marinesco-Sjogren-Like Syndrome. Our group has previously identified the GBA2 c.1780G>C [p.Asp594His] missense mutation, in a Cypriot consanguineous family with spastic ataxia. In this study, we carried out a biochemical characterization of lymphoblastoid cell lines (LCLs) derived from three patients of this family. We found that the mutation strongly reduce NLGase activity both intracellularly and at the plasma membrane level. Additionally, we observed a two-fold increase of GlcCer content in LCLs derived from patients compared to controls, with the C16 lipid being the most abundant GlcCer species. Moreover, we showed that there is an apparent compensatory effect between NLGase and the lysosomal glucosylceramidase (GCase), since we found that the activity of GCase was three-fold higher in LCLs derived from patients compared to controls. We conclude that the c.1780G>C mutation results in NLGase loss of function with abolishment of the enzymatic activity and accumulation of GlcCer accompanied by a compensatory increase in GCase.
topic GBA2
non-lysosomal β-glucosylceramidase
β-glucocerebrosidase
spastic ataxia
glucosylceramide
plasma membrane
lymphoblastoid cell lines
url http://www.mdpi.com/1422-0067/19/10/3099
work_keys_str_mv AT annamalekkou biochemicalcharacterizationofthegba2c1780ggtcmissensemutationinlymphoblastoidcellsfrompatientswithspasticataxia
AT maurasamarani biochemicalcharacterizationofthegba2c1780ggtcmissensemutationinlymphoblastoidcellsfrompatientswithspasticataxia
AT anthidrousiotou biochemicalcharacterizationofthegba2c1780ggtcmissensemutationinlymphoblastoidcellsfrompatientswithspasticataxia
AT christinavotsi biochemicalcharacterizationofthegba2c1780ggtcmissensemutationinlymphoblastoidcellsfrompatientswithspasticataxia
AT sandrosonnino biochemicalcharacterizationofthegba2c1780ggtcmissensemutationinlymphoblastoidcellsfrompatientswithspasticataxia
AT mariospantzaris biochemicalcharacterizationofthegba2c1780ggtcmissensemutationinlymphoblastoidcellsfrompatientswithspasticataxia
AT elenachiricozzi biochemicalcharacterizationofthegba2c1780ggtcmissensemutationinlymphoblastoidcellsfrompatientswithspasticataxia
AT elenizambapapanicolaou biochemicalcharacterizationofthegba2c1780ggtcmissensemutationinlymphoblastoidcellsfrompatientswithspasticataxia
AT massimoaureli biochemicalcharacterizationofthegba2c1780ggtcmissensemutationinlymphoblastoidcellsfrompatientswithspasticataxia
AT nicolettaloberto biochemicalcharacterizationofthegba2c1780ggtcmissensemutationinlymphoblastoidcellsfrompatientswithspasticataxia
AT kyproulachristodoulou biochemicalcharacterizationofthegba2c1780ggtcmissensemutationinlymphoblastoidcellsfrompatientswithspasticataxia
_version_ 1725985793066926080